Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing price barriers to pediatric fever care in Uganda
PACTR202609846349816Not yet recruiting
- Sponsor
- Weiss Asset Management Foundation
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of azithromycin in fever (3 arms), sponsored by Weiss Asset Management Foundation. Primary endpoint: Illness duration. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
fever
Beyond the preview
Go deeper on PACTR202609846349816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609846349816.